USA has created a new business unit specializing in the healthcare
and life sciences sectors; seasoned industry veteran John Amos has
joined ORIX Health and Life Sciences as CEO.
ORIX Health and Life Sciences will invest in operating companies within
the sector and stimulate the growth of the companies through
acquisitions, capital and operating assistance from ORIX USA.
ORIX USA is a Dallas, Texas-based diversified financial conglomerate
with both direct investment portfolios and ownership of operating
subsidiaries in investment banking (Houlihan Lokey), multifamily
mortgage lending (RED Capital Group) and asset management (Mariner
Investment Group). With Health and Life Sciences, ORIX USA will expand
its portfolio of operating companies into healthcare, a large and
growing sector of the economy.
“As with previous acquisitions including Houlihan Lokey, RED Capital
Group and Mariner Investment Group, our interest is in businesses with
strong management teams, which will be maintained as separate entities
under ORIX USA’s governance and supported by our investment capital,”
said ORIX USA CEO Jim Thompson. “With the launch of ORIX USA Health and
Life Sciences, this strategy is broadening from financial firms to the
CEO John Amos has a strong background in operating health care companies
having worked at both McKesson and Bristol Meyer. As CEO of Oncology
Therapeutic Networks (OTN), Amos grew OTN through a string of
successfully executed acquisitions before selling it to McKesson
Corporation. Amos also has served on the boards of Apollo Health Street,
Prodigy Health, Navigating Cancer, CITIC Pharmaceuticals, Aesyntix
Health and as the venture partner for Bioveda China Fund.
About ORIX USA
ORIX USA is a diversified financial company with more than $5 billion of
assets in sectors spanning commercial finance, venture finance,
commercial real estate, mortgage backed securities and public finance.
Operating subsidiaries include Houlihan Lokey, Mariner Investment Group
and RED Capital Group. Headquartered in Dallas Texas, ORIX USA and its
subsidiaries have approximately 1,400 employees, $25 billion of assets
managed for others and offices in most major cities including New York,
Los Angeles, Milwaukee, Atlanta as well as Hong Kong and Tokyo.
ORIX USA Corporation is a wholly owned subsidiary of ORIX Corporation, a
publicly traded international diversified financial services firm
headquartered in Tokyo, listed on the Tokyo (8591) and New York
(NYSE:IX) stock exchanges with operations in over 27 countries worldwide.